States are considered “laboratories of democracy,” allowing experimentation with innovative reforms that could potentially be adopted at the national level. To test new approaches in their Medicaid programs, states have embraced Section 1115 waivers, which permit innovations that do not meet federal program rules, but still promote the program’s objectives.
In the not-too-distant future, individuals may be able to learn their risk of developing Alzheimer’s disease through biomarkers – measures of disease activity – detected up to 20 years before symptoms present. This information would allow individuals (and their loved ones) to prepare for future cognitive and functional decline, but it also has implications for the purchase of private long-term care insurance.
Financial conflicts of interest between the drug and device industry and physicians have long been recognized, but the frequency and scope of such conflicts between industry and patient advocacy organizations (PAOs) are less understood.
In a push to encourage “personal responsibility,” the Centers for Medicare and Medicaid Services (CMS) has approved work requirements as a condition for receiving Medicaid benefits in four states - Kentucky, Indiana, Arkansas, and most recently New Hampshire, with applications from other states pending.
As policymakers debate the best way to address pressing health care challenges, one ‘opinion’ that is sometimes drowned out is that of the public. At a recent Penn LDI seminar, Mollyann Brodie, PhD, MS, Senior Vice President for Executive Operations and Executive Director of Public Opinion and Survey Research at the Kaiser Family Foundation (KFF), underscored the value of public polling when it comes to health care policy and politics.
The Food and Drug Administration (FDA) recently approved the first digital pill that tracks if patients have taken their medication. Our experts weighed in on the potential benefits of the new technology, as well as the potential for abuse.
Editor's Note: On November 7, 2017, University of Notre Dame employees received an email saying that contraceptive coverage will continue for health care plan members at no cost, because the third-party administrator will continue to provide the coverage free of charge.